Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0M8PM
|
||||
| Former ID |
DIB003356
|
||||
| Drug Name |
IRX-4
|
||||
| Synonyms |
IRX-2 + tumor-specific antigen (cancer), IRx Therapeutics
|
||||
| Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Preclinical | [548530] | ||
| Company |
IRX Therapeutics Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Glutamate carboxypeptidase II | Target Info | Immunomodulator (Immunostimulant) | [532510] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| TNFalpha Signaling Pathway | |||||
| WikiPathways | One Carbon Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.